C123H131N31O12 — CID 163965480
4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine (PubChem CID 163965480) has the molecular formula C123H131N31O12 and a molecular weight of 2235.61 g/mol. Its IUPAC name is 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine.
| Compound Name | 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine |
|---|---|
| PubChem CID | 163965480 |
| Molecular Formula | C123H131N31O12 |
| Molecular Weight | 2235.61 g/mol |
| Exact Mass | 2234.06 |
| IUPAC Name | 4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(1-methylpyrazol-4-yl)ethoxy]pyrimidin-4-yl]morpholine;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-[2-(2-methylpyrazol-3-yl)ethoxy]pyrimidin-4-yl]morpholine;(1R)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;(1S)-2-[4-[3-(3-methylphenyl)pyrazol-1-yl]-6-morpholin-4-ylpyrimidin-2-yl]oxy-1-phenylethanol;4-[6-[3-(3-methylphenyl)pyrazol-1-yl]-2-(pyridazin-3-ylmethoxy)pyrimidin-4-yl]morpholine |
| SMILES | Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCCc4ccnn4C)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCCc4cnn(C)c4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OC[C@@H](O)c4ccccc4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OC[C@H](O)c4ccccc4)n3)n2)c1.Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(OCc4cccnn4)n3)n2)c1 |
| InChI | InChI=1S/2C26H27N5O3.2C24H27N7O2.C23H23N7O2/c2*1-19-6-5-9-21(16-19)22-10-11-31(29-22)25-17-24(30-12-14-33-15-13-30)27-26(28-25)34-18-23(32)20-7-3-2-4-8-20;1-18-4-3-5-19(16-18)21-7-10-31(28-21)23-17-22(30-11-14-32-15-12-30)26-24(27-23)33-13-8-20-6-9-25-29(20)2;1-18-4-3-5-20(14-18)21-6-8-31(28-21)23-15-22(30-9-12-32-13-10-30)26-24(27-23)33-11-7-19-16-25-29(2)17-19;1-17-4-2-5-18(14-17)20-7-9-30(28-20)22-15-21(29-10-12-31-13-11-29)25-23(26-22)32-16-19-6-3-8-24-27-19/h2*2-11,16-17,23,32H,12-15,18H2,1H3;3-7,9-10,16-17H,8,11-15H2,1-2H3;3-6,8,14-17H,7,9-13H2,1-2H3;2-9,14-15H,10-13,16H2,1H3/t2*23-;;;/m10.../s1 |
| InChIKey | SLIHVQRMDGNKOU-FBKXPWLNSA-N |
| XLogP | 15.68 |
| TPSA | 428.38 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 43 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 166 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2235.61 |
| LogP ≤ 5 | 15.68 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 43 |